The the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of XNW3009 in Health Subject
Clinical trial NCT04040907 · COMPLETED
Trial details
- NCT number
- NCT04040907
- Sponsor
- Evopoint Biosciences Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-13
- Primary completion
- 2021-01-20
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.